Viewing Study NCT06261359


Ignite Creation Date: 2025-12-24 @ 2:40 PM
Ignite Modification Date: 2026-01-01 @ 8:59 AM
Study NCT ID: NCT06261359
Status: RECRUITING
Last Update Posted: 2024-09-04
First Post: 2024-02-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of CEND-1 With Chemotherapy as First-Line Therapy in Patients With Pancreatic Ductal Adenocarcinoma
Sponsor: Qilu Pharmaceutical Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module